Cumberland Pharmaceuticals Inc. Stock Redeemed or Called During Period, Value
Cumberland Pharmaceuticals Inc. (CPIX) reported Stock Redeemed or Called During Period, Value of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodValue · last filed 2024-03-13
- Cumberland Pharmaceuticals Inc. stock redeemed or called during period, value for the quarter ending 2022-09-30 was $399.60K.
- Cumberland Pharmaceuticals Inc. stock redeemed or called during period, value for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. stock redeemed or called during period, value for fiscal 2022 was $399.60K.
- Cumberland Pharmaceuticals Inc. stock redeemed or called during period, value for fiscal 2021 was $0.00.
- Cumberland Pharmaceuticals Inc. stock redeemed or called during period, value for fiscal 2011 was $4.25M, a 13.09% decline from fiscal 2010.
| Period end | Stock Redeemed or Called During Period, Value 3 month | Stock Redeemed or Called During Period, Value 12 month |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-13 | |
| 2022-12-31 | $399.60K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $399.60K 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 | |
| 2011-12-31 | $4.25M 10-K · filed 2012-03-07 | |
| 2010-12-31 | $4.89M 10-K · filed 2012-03-07 | |
| 2009-12-31 | $52.23K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |